The price of WAR: AMR
Ceftazidime/avibactam and aztreonam is highlighted as a promising regimen for MDR infections in conflict zones.
Authors
- Tracy L. Lemonovich
- Federico Perez (ORCID: https://orcid.org/0000-0003-2642-3266)
- Steven H. Marshall (ORCID: https://orcid.org/0009-0003-1811-2633)
- Robert A Bonomo
- Laura J. Rojas (ORCID: https://orcid.org/0000-0003-4410-1658)
- Adam Hirschfeld
Institutions
- MetroHealth (US)
- Louis Stokes Cleveland VA Medical Center (US)
- University School (US)
- MetroHealth Medical Center (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1093/jacamr/dlaf083
- Citations
- 2
- Primary Topic
- Disaster Response and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.03
Funders
- U.S. Department of Veterans Affairs
- Office of Research and Development
- Biomedical Laboratory Research and Development, VA Office of Research and Development
- Department of Veterans' Affairs, Australian Government
- Norges Idrettshøgskole